OvaRenew is ready for proving its efficacy with clinical study. The product will be IP protected.
Further stakeholders are invited to participate:
1. CONTRACT MANUFACTURERS (sub-contractor or partner)
OvaRenew will be distributed and marketed internationally by local distributors, we therefore invite interested companies with the right match of competencies to contact us for further information at email@example.com. We are especially looking for distributors who:
• Have a strong local pharmacy presence : companies with a proven track record of getting innovative products listed at local pharmacies.
• Sell fertility OTC and Rx products : there are significant synergies with other fertility products.